<?xml version="1.0" encoding="UTF-8"?>
<ref id="B299-viruses-12-00110">
 <label>299.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Stein</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Castanotto</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>FDA-approved oligonucleotide therapies in 2017</article-title>
  <source>Mol. Ther.</source>
  <year>2017</year>
  <volume>25</volume>
  <fpage>1069</fpage>
  <lpage>1075</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ymthe.2017.03.023</pub-id>
  <?supplied-pmid 28366767?>
  <pub-id pub-id-type="pmid">28366767</pub-id>
 </element-citation>
</ref>
